414 related articles for article (PubMed ID: 18356552)
1. Homocysteine or renal impairment: which is the real cardiovascular risk factor?
Potter K; Hankey GJ; Green DJ; Eikelboom JW; Arnolda LF
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1158-64. PubMed ID: 18356552
[TBL] [Abstract][Full Text] [Related]
2. Glomerular filtration rate as measured by serum cystatin C is an important determinant of plasma homocysteine and serum methylmalonic acid in the elderly.
Lewerin C; Ljungman S; Nilsson-Ehle H
J Intern Med; 2007 Jan; 261(1):65-73. PubMed ID: 17222169
[TBL] [Abstract][Full Text] [Related]
3. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
[TBL] [Abstract][Full Text] [Related]
4. Role of impaired renal function as a cause of elevated plasma homocysteine concentration in psychogeriatric patients.
Nilsson K; Gustafson L; Hultberg B
Scand J Clin Lab Invest; 2002; 62(5):385-9. PubMed ID: 12387585
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive treatment and homocysteine concentrations.
Westphal S; Rading A; Luley C; Dierkes J
Metabolism; 2003 Mar; 52(3):261-3. PubMed ID: 12647260
[TBL] [Abstract][Full Text] [Related]
6. Association between global leukocyte DNA methylation, renal function, carotid intima-media thickness and plasma homocysteine in patients with stage 2-4 chronic kidney disease.
Nanayakkara PW; Kiefte-de Jong JC; Stehouwer CD; van Ittersum FJ; Olthof MR; Kok RM; Blom HJ; van Guldener C; ter Wee PM; Smulders YM
Nephrol Dial Transplant; 2008 Aug; 23(8):2586-92. PubMed ID: 18287179
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine, renal disease and cardiovascular disease in a remote Australian Aboriginal community.
McDonald S; Maguire G; Duarte N; Wang XL; Hoy W
Intern Med J; 2005 May; 35(5):289-94. PubMed ID: 15845111
[TBL] [Abstract][Full Text] [Related]
8. Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-controlled trial.
Potter K; Lenzo N; Eikelboom JW; Arnolda LF; Beer C; Hankey GJ
Cerebrovasc Dis; 2009; 27(3):259-65. PubMed ID: 19202330
[TBL] [Abstract][Full Text] [Related]
9. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
10. Association between homocysteinemia and renal function in patients with type 2 diabetes mellitus.
Ozmen B; Ozmen D; Turgan N; Habif S; Mutaf I; Bayindir O
Ann Clin Lab Sci; 2002; 32(3):279-86. PubMed ID: 12175091
[TBL] [Abstract][Full Text] [Related]
11. The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis.
Potter K; Hankey GJ; Green DJ; Eikelboom J; Jamrozik K; Arnolda LF
BMC Cardiovasc Disord; 2008 Sep; 8():24. PubMed ID: 18803866
[TBL] [Abstract][Full Text] [Related]
12. Cystatin C and the risk of death and cardiovascular events among elderly persons.
Shlipak MG; Sarnak MJ; Katz R; Fried LF; Seliger SL; Newman AB; Siscovick DS; Stehman-Breen C
N Engl J Med; 2005 May; 352(20):2049-60. PubMed ID: 15901858
[TBL] [Abstract][Full Text] [Related]
13. Circulating homocysteine and large arterial stiffness and thickness in a population-based sample of middle-aged and elderly men.
Nakhai-Pour HR; Grobbee DE; Bots ML; Muller M; van der Schouw YT
J Hum Hypertens; 2007 Dec; 21(12):942-8. PubMed ID: 17597801
[TBL] [Abstract][Full Text] [Related]
14. Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial.
Bostom AG; Carpenter MA; Kusek JW; Hunsicker LG; Pfeffer MA; Levey AS; Jacques PF; McKenney J;
Am Heart J; 2006 Sep; 152(3):448.e1-7. PubMed ID: 16923411
[TBL] [Abstract][Full Text] [Related]
15. Relationship of serum cystatin C to peritoneal and renal clearance measures in peritoneal dialysis: a cross-sectional study.
Delaney MP; Stevens PE; Al Hasani M; Stowe HJ; Judge C; Lamb EJ
Am J Kidney Dis; 2008 Feb; 51(2):278-84. PubMed ID: 18215705
[TBL] [Abstract][Full Text] [Related]
16. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease.
Shechter M; Issachar A; Marai I; Koren-Morag N; Freinark D; Shahar Y; Shechter A; Feinberg MS
Int J Cardiol; 2009 May; 134(1):52-8. PubMed ID: 18479768
[TBL] [Abstract][Full Text] [Related]
17. The homocysteine paradox.
Rodionov RN; Lentz SR
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1031-3. PubMed ID: 18495971
[No Abstract] [Full Text] [Related]
18. Total plasma homocysteine in hospitalized elderly: associations with vitamin status and renal function.
Ramel A; Jonsson PV; Bjornsson S; Thorsdottir I
Ann Nutr Metab; 2007; 51(6):527-32. PubMed ID: 18097138
[TBL] [Abstract][Full Text] [Related]
19. Inflammation, homocysteine and carotid intima-media thickness.
Baptista AP; Cacdocar S; Palmeiro H; Faísca M; Carrasqueira H; Morgado E; Sampaio S; Cabrita A; Silva AP; Bernardo I; Gome V; Neves PL
Rev Port Cardiol; 2008 Jan; 27(1):39-48. PubMed ID: 18447036
[TBL] [Abstract][Full Text] [Related]
20. Determinants and associations of homocysteine and prothrombotic risk factors in Kuwaiti patients with cerebrovascular accident.
Mojiminiyi OA; Marouf R; Al Shayeb AR; Qurtom M; Abdella NA; Al Wazzan H; Al Humood S; Samad MA; El-Muzaini H
Med Princ Pract; 2008; 17(2):136-42. PubMed ID: 18287798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
